Introduced by Smith+Nephew in the US during 2024, the CARTIHEAL Implant is rapidly transforming the cartilage repair ...
CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more ...
ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target. Cancer ...
Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming ...
Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient ou ...
Dr. Meltzer joins Avilar as the company advances its lead ATAC program toward the clinic. The program is an ATAC designed to ...
The incidence of melanoma is steadily rising, with annual cases projected to increase by more than 50% between 2020 and 2040.
Motivista is a prescription digital therapeutic indicated for the treatment of negative symptoms of schizophrenia as an ...
Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized ...
EDINBURGH, Scotland-- (BUSINESS WIRE)--RoslinCT, a leading global cell therapy Contract Development and Manufacturing ...
Additionally, Thermo Fisher is expanding small molecule capabilities through its collaboration with AustinPx, giving ...
Financing will advance a potential once-daily oral treatment designed to restore blood vessel stability in HHT, a serious inherited bleeding disorder with no approved therapies. periSCOPE platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results